세계의 소아 당뇨병 관리 시장 규모는 2024년에 56억 6,000만 달러로 평가되었고, 2030년에는 100억 1,000만 달러에 이를 것으로 예측되며, CAGR은 9.94%를 나타낼 전망입니다.
세계의 소아 당뇨병 관리 시장은 소아 및 청소년에서 당뇨병 유병률이 증가함에 따라 혁신적인 관리 솔루션에 대한 수요를 견인하고 큰 성장을 이루고 있습니다. 소아 당뇨병, 특히 제1형 당뇨병은 당뇨병성 케톤산증과 같은 급성 합병증과 성장 및 발달에 미치는 장기적인 영향을 예방하기 위해 지속적인 모니터링과 정확한 인슐린 투여가 필요합니다. 지속적인 포도당 모니터링(CGM) 시스템, 자동 인슐린 투여(AID) 장치, 스마트 인슐린 펌프 등의 기술의 진보로 보다 정확하고 편리한 혈당 관리가 가능해지고 있습니다. 병원, 클리닉, 재택 케어 현장에서는 이러한 솔루션을 케어 프로토콜에 통합하는 경우가 늘어나 환자의 어드레싱과 임상 결과를 개선하고 있습니다. 조기 개입과 효과적인 당뇨병 관리의 중요성에 대한 학부모, 간병인 및 의료 제산업체의 의식 증가도 시장 확대에 기여합니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 56억 6,000만 달러 |
| 시장 규모 : 2030년 | 100억 1,000만 달러 |
| CAGR : 2025-2030년 | 9.94% |
| 급성장 부문 | 비연결형 기기 |
| 최대 시장 | 북미 |
시장을 견인하는 몇 가지 주요 요인이 있습니다. 소아 당뇨병의 세계적인 증가로 지속적인 모니터링과 개별 치료가 필요한 환자 수가 증가하고 있습니다. 첨단 인슐린 전달 시스템과 CGM 장치의 채용은 혈당 조절을 향상시켜 급성 긴급 상황과 장기적인 합병증의 위험을 감소시킵니다. 의료 서비스 제산업체는 환자 중심의 접근 방식을 강조하고, 개별 어린이의 필요에 맞게 치료 계획을 세우고, 디지털 도구를 활용하여 포도당 수준을 추적하고, 인슐린 복용량을 조정하며, 원격 모니터링을 수행합니다. 예측 분석 및 데이터 중심의 의사 결정과 같은 의료 기술의 끊임없는 진보로 임상의는 고위험 에피소드를 예측하고 적극적으로 개입할 수 있습니다. 의료기기 기업에 의한 R&D 투자 증가로 소아 당뇨병 관리 솔루션의 기술 혁신이 가속화되고 환자와 의료 종사자 모두에게 더욱 안전하고 효율적이며 사용자 친화적인 옵션을 제공하고 있습니다.
시장의 새로운 동향으로는 CGM 데이터와 인슐린 전달 시스템을 통합하고 실시간으로 조정하는 커넥티드 헬스케어 기술의 통합을 들 수 있습니다. 원격 의료 플랫폼은 원격 모니터링 및 컨설팅을 지원하며 가족이 집에서 소아 당뇨병을 관리하면서 통원 횟수를 줄이는 데 도움이 됩니다. 알고리즘 중심의 인슐린 투여를 포함한 개인화된 치료 접근법은 치료의 정확성과 효능을 향상시킵니다. 시장은 강력한 성장이 예상되는 것, 지역에 따라서는 인지도가 한정적인 것, 선진적인 기기의 가격이 높게 이용하기 어려운 것, 이러한 기술을 효과적으로 사용하려면 의료 종사자에게 전문적인 트레이닝이 필요하다는 등의 과제에 직면하고 있습니다. 규제상의 장애물과 새로운 장비의 장기적인 안전과 효능에 대한 우려는 보급을 늦출 수 있습니다. 교육, 정책 지원, 혁신을 통해 이러한 과제를 해결하는 것은 세계의 소아 당뇨병 관리 시장 성장을 지속하고 당뇨병과 함께 사는 아이들에게 더 나은 결과를 가져오는 데 필수적입니다.
소아 당뇨병의 유병률 상승
고급 장치 및 치료법의 높은 비용
디지털 건강 솔루션 통합
The Global Pediatric Diabetes Management Market was valued at USD 5.66 Billion in 2024 and is expected to reach USD 10.01 Billion by 2030 with a CAGR of 9.94%. The Global Pediatric Diabetes Management Market is witnessing significant growth due to the increasing prevalence of diabetes among children and adolescents, which is driving demand for innovative management solutions. Pediatric diabetes, particularly type 1 diabetes, requires continuous monitoring and precise insulin administration to prevent acute complications such as diabetic ketoacidosis and long-term effects on growth and development. Advances in technology, including continuous glucose monitoring (CGM) systems, automated insulin delivery (AID) devices, and smart insulin pumps, are enabling more precise and convenient management of blood glucose levels. Hospitals, clinics, and homecare settings are increasingly integrating these solutions into care protocols, improving patient adherence and clinical outcomes. Growing awareness among parents, caregivers, and healthcare providers regarding the importance of early intervention and effective diabetes management is also contributing to the market's expansion.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 5.66 Billion |
| Market Size 2030 | USD 10.01 Billion |
| CAGR 2025-2030 | 9.94% |
| Fastest Growing Segment | Non-connected Devices |
| Largest Market | North America |
The market is being driven by several key factors. Rising incidence of pediatric diabetes globally is creating a larger patient pool that requires continuous monitoring and personalized care. Adoption of advanced insulin delivery systems and CGM devices enables better glycemic control, reducing the risk of acute emergencies and long-term complications. Healthcare providers are emphasizing patient-centric approaches, tailoring treatment plans to individual children's needs, and leveraging digital tools to track glucose levels, adjust insulin dosing, and provide remote monitoring. Continuous advancements in medical technologies, including predictive analytics and data-driven decision-making, allow clinicians to anticipate high-risk episodes and intervene proactively. Increasing investments in research and development by medical device companies are accelerating innovation in pediatric diabetes management solutions, offering safer, more efficient, and user-friendly options for both patients and healthcare professionals.
Emerging trends in the market include the integration of connected healthcare technologies that combine CGM data with insulin delivery systems for real-time adjustments. Telemedicine platforms are supporting remote monitoring and consultation, helping families manage pediatric diabetes at home while reducing hospital visits. Personalized treatment approaches, including algorithm-driven insulin dosing, are enhancing the precision and effectiveness of care. Despite strong growth prospects, the market faces challenges such as limited awareness in certain regions, high costs of advanced devices that may restrict accessibility, and the need for specialized training of healthcare professionals to use these technologies effectively. Regulatory hurdles and concerns regarding long-term safety and efficacy of new devices may slow adoption. Addressing these challenges through education, policy support, and technological innovation is essential to sustaining growth in the Global Pediatric Diabetes Management Market, ensuring better outcomes for children living with diabetes.
Key Market Drivers
Rising Prevalence of Pediatric Diabetes
A major driver of the Global Pediatric Diabetes Management Market is the rising prevalence of pediatric diabetes, which has been increasing steadily due to a combination of genetic, environmental, and lifestyle factors. Type 1 diabetes remains the most common form among children and adolescents, requiring lifelong insulin therapy and continuous monitoring to prevent acute complications such as diabetic ketoacidosis (DKA) and long-term health issues affecting growth, cardiovascular health, and kidney function. At the same time, the incidence of type 2 diabetes is rising among younger populations, driven by childhood obesity, sedentary lifestyles, and poor dietary habits, creating an additional patient pool that requires regular monitoring, insulin therapy, and lifestyle interventions. According to the International Diabetes Federation, around 1.52 million people aged 20 years had diabetes in 2022, highlighting the significant burden of the disease and underscoring the urgent need for effective management solutions. This dual burden of type 1 and type 2 diabetes is intensifying demand for reliable pediatric diabetes management products and services.
Healthcare providers are recognizing the critical need for early diagnosis and intervention to manage glycemic levels efficiently and prevent complications. Continuous glucose monitoring (CGM) systems, automated insulin delivery (AID) devices, and smart insulin pumps are increasingly being adopted to provide real-time insights, personalized insulin dosing, and predictive alerts for hypoglycemic or hyperglycemic events. Rising prevalence is also driving investment in caregiver education programs and pediatric-specific treatment protocols, ensuring adherence to therapy and effective disease management. The increasing number of children diagnosed with diabetes is prompting healthcare systems, hospitals, and clinics to expand infrastructure, implement advanced monitoring solutions, and integrate digital health tools to improve patient outcomes. This growing patient base, combined with technological advancements and awareness initiatives, is a key factor propelling the expansion of the pediatric diabetes management market globally, reflecting the urgent need for specialized and accessible care solutions for young patients living with diabetes.
Key Market Challenges
High Cost of Advanced Devices and Therapies
A significant challenge facing the Global Pediatric Diabetes Management Market is the high cost of advanced devices and therapies, which limits accessibility for many families, particularly in low- and middle-income regions. Advanced technologies such as continuous glucose monitors (CGM), automated insulin delivery (AID) systems, and smart insulin pumps offer precision, convenience, and improved glycemic control, but their high purchase prices often ranging from USD 1,000-6,000 for pumps and USD 2,000-5,000 annually for CGM sensors create substantial financial barriers. Many families are unable to afford these technologies without adequate insurance coverage or government subsidies, resulting in disparities in pediatric diabetes care. The cost factor affects device adoption and long-term treatment adherence, as children relying on traditional finger-prick glucose meters and manual insulin injections face less precise monitoring, increasing the risk of acute complications such as diabetic ketoacidosis (DKA) and long-term health consequences.
High costs also constrain healthcare providers in standardizing advanced management solutions, especially in emerging markets with limited healthcare budgets. Manufacturers face the challenge of balancing innovation with affordability, as pediatric-specific R&D investments are substantial. To mitigate these barriers, strategies such as developing lower-cost alternatives, expanding insurance coverage, offering patient assistance programs, and implementing government subsidies are critical. Without such measures, the high expense of advanced devices and therapies will continue to impede adoption and limit the overall growth potential of the Global Pediatric Diabetes Management Market.
Key Market Trends
Integration of Digital Health Solutions
The integration of digital health solutions is a transformative trend in the Global Pediatric Diabetes Management Market, significantly enhancing the monitoring and management of pediatric diabetes. Digital health technologies, including mobile applications, cloud-based platforms, and telemedicine tools, allow caregivers and healthcare providers to access real-time data on blood glucose levels, insulin administration, and lifestyle factors. Continuous glucose monitoring (CGM) systems integrated with these platforms provide automated alerts for hypo- or hyperglycemic events, enabling timely interventions and reducing the risk of complications such as diabetic ketoacidosis. Integration of digital platforms with insulin pumps and automated insulin delivery (AID) systems further enhances personalized care by enabling real-time adjustments to insulin dosing based on predictive algorithms and trend analysis.
Remote monitoring capabilities offered by digital solutions allow healthcare professionals to supervise pediatric patients outside hospital settings, improving adherence and reducing the frequency of emergency visits or hospitalizations. These platforms also facilitate better communication between caregivers, patients, and clinicians, ensuring coordinated care and informed decision-making. Data collected through digital health systems can be analyzed to identify patterns in glucose fluctuations, evaluate the effectiveness of treatment protocols, and optimize long-term management strategies. Growing investment in healthcare IT infrastructure, increasing smartphone penetration, and rising awareness among parents and healthcare providers about the benefits of connected care are accelerating adoption of digital solutions. Integration of wearable sensors, artificial intelligence, and predictive analytics is enhancing the precision and efficiency of diabetes management, providing actionable insights and supporting proactive interventions. This convergence of technology and healthcare is shaping a patient-centric, data-driven approach, driving innovation and improving outcomes in pediatric diabetes management across diverse healthcare settings.
In this report, the Global Pediatric Diabetes Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Diabetes Management Market.
Global Pediatric Diabetes Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: